Use of methyl-CCNU and procarbazine in advanced malignant melanoma resistant to DTIC therapy
Didolkar, M.S.; Baffi, R.R.; Catane, R.; Kaufman, J.; Holyoke, E.D.
Cancer Treatment Reports 61(9): 1738-1739
1977
ISSN/ISBN: 0361-5960 PMID: 597824 Document Number: 113468
Document emailed within 1 workday
Related Documents
Einhorn, L.H.; Furnas, B. 1977: Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl-CCNU Cancer Treatment Reports 61(5): 881-883Carmo-Pereira, J.; Costa, F.O.; Pimentel, P.; Henriques, E. 1980: Combination cytotoxic chemotherapy with CCNU, procarbazine, and vincristine in disseminated cutaneous malignant melanoma: 3 years, followup Cancer Treatment Reports 64(1): 143-145
Rossi, A.; Riva, A.; Bonadonna, G. 1975: Methyl-CCNU (NSCU-95441) versus methyl-CCNU plus cyclophosphamide (NSC-26271) in advanced gastrointestinal cancer Cancer ChemoTherapy Reports 59(6): 1161-1162
Bolling, R.; Meyer-Hamme, S.; Schauder, S. 1980: Photosensitization with DTIC therapy in metastatic malignant melanoma Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 31(11): 602-605
Kane, R.C.; Cashdollar, M.R.; Bernath, A.M. 1978: Treatment of advanced colorectal cancer with methyl-CCNU plus 5-day 5-fluorouracil infusion Cancer Treatment Reports 62(10): 1521-1525
Karakousis, C.P.; Didolkar, M.S.; Han, T. 1981: Chemoimmunotherapy (DTIC and Corynebacterium parvum) for disseminated malignant melanoma Cancer Treatment Reports 65(9-10): 925-926
Karakousis, C.P.; Didolkar, M.S.; Lopez, R.; Baffi, R.; Moore, R.; Holyoke, E.D. 1979: Chemoimmunotherapy (DTIC and Corynebacterium parvum) as adjuvant treatment in malignant melanoma Cancer Treatment Reports 63(11-12): 1739-1743
Samson, M.K.; Baker, L.H.; Fraile, R.J.; Izbicki, R.M.; Vaitkevicius, V.K. 1977: Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients Cancer Treatment Reports 61(1): 59-64
Ahmann, D.L.; Edmonson, J.H.; Frytak, S.; Kvols, L.K.; Bisel, H.F.; Rubin, J. 1978: Phase Ii study of ICRF-159 versus combination cis-dichlorodiammineplatinum(II) and DTIC in patients with disseminated malignant melanoma Cancer Treatment Reports 62(1): 151-153
Omura, G.A.; Shingleton, H.M.; Creasman, W.T.; Blessing, J.A.; Boronow, R.C. 1978: Chemotherapy of gynecologic cancer with nitrosoureas: a randomized trial of CCNU and methyl-CCNU in cancers of the cervix, corpus, vagina, and vulva Cancer Treatment Reports 62(5): 833-835
Gagliano, R.G.; Panettiere, F.J.; Haas, C.D.; Baker, L.; Hewlett, J.; Stuckey, W.J.; O'Bryan, R.M.; Bottomley, R.; Heilburn, L.K. 1981: Evaluation of beta-2'-deoxythioguanosine combined with methyl-CCNU or mitomycin in advanced colorectal cancer. a Southwest Oncology Group study Cancer Clinical Trials 4(4): 401-405
Huber, H.; Grünewald, K. 1978: Dacarbacine (DTIC) in the therapy of a malignant disease. a review Wiener Klinische Wochenschrift 90(24): 861-864
Gobbi, P.G.; Pieresca, C.; Cavanna, L.; Corbella, F.; Vallisa, D.; Federico, M.; Formisano, R.; Carotenuto, M.; Merli, F.; Callea, V.; Angrilli, F.; Silingardi, V. 1996: CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. a prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL) Haematologica 81(6): 503-512
Miura, T.; Ishikawa, S. 1970: Malignant melanoma--synopses from the seminar on malignant melanoma by International Group for the Clinical Study of Melanoma Gan no Rinsho. Japan Journal of Cancer Clinics 16(11): 1064-1070
Jaques, D.P.; Coit, D.G.; Brennan, M.F. 1989: Major amputation for advanced malignant melanoma Surgery Gynecology and Obstetrics 169(1): 1-6
Wallack, M.K. 1979: The treatment of advanced malignant melanoma with vaccina oncolysates La Nouvelle Presse Medicale 8(23): 1919-1921
Hochster, H.; Levin, M.; Speyer, J.; Dunleavy, S.; Harris, M.; Roses, D.; Golomb, F.; Muggia, F. 1985: Single-dose dacarbazine and dactinomycin in advanced malignant melanoma Cancer Treatment Reports 69(1): 39-42
Uzuka, Y.; Saito, Y.; Takahashi, H.; Komatsu, M.; Ito, T. 1989: Combination chemotherapy of multiple myeloma--BCNU.cyclophosphamide.procarbazine.prednisolone and MCNU.cyclophosphamide.procarbazine.prednisolone therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(6): 2269-2273
de Braud, F.; Biganzoli, L.; Bajetta, E.; Colleoni, M.; Zampino, M.G. 1993: Subcutaneous low-dose interleukin-2 plus alpha interferon in advanced malignant melanoma Tumori 79(3): 187-190
Creagan, E.T.; Ahmann, D.L.; Schutt, A.J.; Green, S.J. 1982: Phase Ii study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma Cancer Treatment Reports 66(6): 1425-1426